BR112023000521A2 - Tensoativos de aminoácidos ramificados para uso em produtos de cuidados com a saúde - Google Patents

Tensoativos de aminoácidos ramificados para uso em produtos de cuidados com a saúde

Info

Publication number
BR112023000521A2
BR112023000521A2 BR112023000521A BR112023000521A BR112023000521A2 BR 112023000521 A2 BR112023000521 A2 BR 112023000521A2 BR 112023000521 A BR112023000521 A BR 112023000521A BR 112023000521 A BR112023000521 A BR 112023000521A BR 112023000521 A2 BR112023000521 A2 BR 112023000521A2
Authority
BR
Brazil
Prior art keywords
formulations
healthcare
active
amino acid
drugs
Prior art date
Application number
BR112023000521A
Other languages
English (en)
Inventor
Asirvatham Edward
Original Assignee
Advansix Resins & Chemicals Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advansix Resins & Chemicals Llc filed Critical Advansix Resins & Chemicals Llc
Publication of BR112023000521A2 publication Critical patent/BR112023000521A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Detergent Compositions (AREA)

Abstract

TENSOATIVOS DE AMINOÁCIDOS RAMIFICADOS PARA USO EM PRODUTOS DE CUIDADOS COM A SAÚDE. Formulações de cuidados com a saúde, incluindo tensoativos inventivos, ingrediente ativo formulado como sólidos, líquidos ou emulsões. A presente revelação fornece formulações de produtos de cuidados com a saúde, tais como: fármacos comercializados sob prescrição médica, fármacos isentos de prescrição; suplementos minerais, herbais e/ou vitaminas; fármacos administrados em hospitais, clínicas, consultórios médicos e locais de cuidados paliativos; vacinas, transplantes e/ou enxertos e/ou infusões de tecido, órgão e célula; e formulações de cuidados com ferimentos incluindo pomadas tópicas, loções, produtos de limpeza, lenços, bandagens e curativos. O ativo pode ser incluído nas formulações como um soluto, um solvente, uma partícula ou um componente imiscível em óleo da formulação. O ativo pode ser incluído em comprimidos, cápsulas, tinturas, líquidos ou emulsões. As formulações de cuidados com a saúde inventivas incluem formulações adequadas para a administração oral, tópica e/ou por injeção.
BR112023000521A 2020-07-13 2021-07-12 Tensoativos de aminoácidos ramificados para uso em produtos de cuidados com a saúde BR112023000521A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063051190P 2020-07-13 2020-07-13
PCT/US2021/041340 WO2022015675A1 (en) 2020-07-13 2021-07-12 Branched amino acid surfactants for use in healthcare products

Publications (1)

Publication Number Publication Date
BR112023000521A2 true BR112023000521A2 (pt) 2023-01-31

Family

ID=77265203

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023000521A BR112023000521A2 (pt) 2020-07-13 2021-07-12 Tensoativos de aminoácidos ramificados para uso em produtos de cuidados com a saúde

Country Status (11)

Country Link
US (1) US11857515B2 (pt)
EP (1) EP4178537A1 (pt)
JP (1) JP2023534938A (pt)
KR (1) KR20230051181A (pt)
CN (1) CN116113398A (pt)
AU (1) AU2021307397A1 (pt)
BR (1) BR112023000521A2 (pt)
CA (1) CA3185041A1 (pt)
MX (1) MX2023000604A (pt)
WO (1) WO2022015675A1 (pt)
ZA (1) ZA202301109B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230048327A (ko) * 2020-07-13 2023-04-11 어드밴식스 레진즈 앤드 케미컬즈 엘엘씨 잉크, 페인트, 및 접착제를 위한 분지형 아미노산 계면활성제

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4176232A (en) 1968-06-27 1979-11-27 Rohm And Haas Company Sulfonic acid salts of acyloxyalkylamines
US4550137A (en) 1983-03-28 1985-10-29 Ppg Industries, Inc. Lactam derived salts of sulfonic acids as latent acid catalysts
JPH01190798A (ja) 1988-01-27 1989-07-31 Kao Corp 漂白剤組成物
AU4712189A (en) 1989-01-03 1990-07-12 Amway Corporation Nonionic laundry detergent composition
JP3425227B2 (ja) 1994-07-15 2003-07-14 花王株式会社 液体漂白剤組成物
ES2187564T3 (es) 1994-07-27 2003-06-16 Kao Corp Composicion para suavizante liquido y sal de amonio cuaternario.
JP3502680B2 (ja) 1995-01-19 2004-03-02 花王株式会社 第４級アンモニウム塩の製造方法
JP3502679B2 (ja) 1995-01-19 2004-03-02 花王株式会社 第４級アンモニウム塩の製造方法
JP3563473B2 (ja) 1995-02-24 2004-09-08 花王株式会社 新規な第４級アンモニウム塩及びその製造法
JP3221811B2 (ja) 1995-02-27 2001-10-22 花王株式会社 液体柔軟仕上剤組成物
JP3469974B2 (ja) 1995-10-09 2003-11-25 花王株式会社 液体柔軟仕上剤組成物
GB2310659A (en) 1996-02-27 1997-09-03 Procter & Gamble Cationic detergent compounds
DE19831702A1 (de) 1998-07-15 2000-01-20 Henkel Kgaa Nichtwäßrige Flüssigwaschmittel mit Bleiche
JP4357656B2 (ja) 1999-08-06 2009-11-04 花王株式会社 第４級アンモニウム塩
DE10021538B4 (de) 2000-05-03 2008-06-19 Henkel Kgaa Wäschenachbehandlungsmittel mit Farbschutz
CN100345953C (zh) 2001-03-07 2007-10-31 宝洁公司 适用于对存在有残余洗涤剂的织物进行附加漂洗的调理组合物
EP1502942A1 (en) 2003-07-29 2005-02-02 Clariant International Ltd. Solid softener composition
JP4156467B2 (ja) 2003-08-06 2008-09-24 花王株式会社 融解温度が降下された４級アンモニウム塩含有組成物の製造法
DE602004008217T2 (de) 2004-03-29 2008-05-15 Clariant Produkte (Deutschland) Gmbh Einfach dispergierbare konzentrierte Esterquat Zusammensetzungen
JP5715339B2 (ja) 2007-01-12 2015-05-07 ノバルティス アーゲー ５−ビフェニル−４−アミノ−２−メチルペンタン酸の製造方法
JP2012116755A (ja) 2010-11-29 2012-06-21 Asahi Kasei Fibers Corp 水性毛髪化粧料
DE102011086924A1 (de) 2011-11-23 2013-05-23 Henkel Ag & Co. Kgaa Haarkonditionierende Mittel
WO2013185346A1 (en) 2012-06-15 2013-12-19 Rhodia Operations Method to recover or increase water absorbency of polyester textile
JP2014129269A (ja) 2012-12-28 2014-07-10 Kao Corp オレフィンの製造方法
DE102013214081A1 (de) 2013-07-18 2015-01-22 Evonik Industries Ag Neue aminosäuremodifizierte Siloxane, Verfahren zu ihrer Herstellung und Anwendung
US20160340610A1 (en) 2014-01-17 2016-11-24 Rhodia Operations Method for stabilizing a softening composition
BR112016027568B1 (pt) 2014-06-18 2022-02-22 Rhodia Operations Composição compreendendo um composto amônio quaternário, um polissacarídeo catiônico, um polissacarídeo não iônico e um material de fragrância ou perfume
US10717947B2 (en) 2014-12-22 2020-07-21 Rhodia Operations Solid composition comprising a quaternary ammonium compound and polysaccharide, the process and use thereof
WO2016101980A1 (en) 2014-12-22 2016-06-30 Rhodia Operations A solid composition comprising a polysaccharide and a hydrophobic compound, the process and use thereof
US20180002639A1 (en) 2015-01-16 2018-01-04 Rhodia Operations Method for reducing greying of a fabric
WO2018081480A1 (en) 2016-10-26 2018-05-03 Acuitas Therapeutics, Inc. Lipid nanoparticle formulations
DE102015223826A1 (de) 2015-12-01 2016-09-15 Henkel Ag & Co. Kgaa Leistungsstarke Haarbehandlungsmittel mit strukturstärkendem Effekt
WO2017100992A1 (en) 2015-12-15 2017-06-22 Rhodia Operations Compositions comprising quat and polysaccharides
WO2017101743A1 (en) 2015-12-15 2017-06-22 Rhodia Operations Method for enhancing stability of composition by using quat and polysaccharides
BR112018074072A2 (pt) 2016-05-26 2019-03-06 Rhodia Operations composição sólida para a purificação do açúcar
CN109890363A (zh) 2016-10-28 2019-06-14 荷兰联合利华有限公司 包含表面改性颗粒和非挥发性官能化硅酮的个人护理组合物
EP3555360A4 (en) 2016-12-15 2020-07-15 Rhodia Operations COMPOSITION FOR TREATMENT OF FABRICS
WO2018191719A1 (en) * 2017-04-13 2018-10-18 Acuitas Therapeutics, Inc. Lipid delivery of therapeutic agents to adipose tissue
CN116693411A (zh) 2017-04-28 2023-09-05 爱康泰生治疗公司 用于递送核酸的新型羰基脂质和脂质纳米颗粒制剂
US11524932B2 (en) * 2017-08-17 2022-12-13 Acuitas Therapeutics, Inc. Lipids for use in lipid nanoparticle formulations
WO2019110371A1 (en) 2017-12-05 2019-06-13 Basf Se Organic sulfonic acid salts of amino acid esters and process for their preparation
CN116615101A (zh) * 2020-07-13 2023-08-18 艾德凡斯化学公司 用于农用产品的支链氨基酸表面活性剂
EP4179056A2 (en) * 2020-07-13 2023-05-17 AdvanSix Resins & Chemicals LLC Branched amino acid surfactants for electronics products
KR20230048327A (ko) * 2020-07-13 2023-04-11 어드밴식스 레진즈 앤드 케미컬즈 엘엘씨 잉크, 페인트, 및 접착제를 위한 분지형 아미노산 계면활성제
CN116194548A (zh) * 2020-07-13 2023-05-30 艾德凡斯化学公司 用于油气开采的支链氨基酸表面活性剂
AU2021310198A1 (en) * 2020-07-13 2023-03-09 Advansix Resins & Chemicals Llc Branched amino acid surfactants for personal care and cosmetic products
AU2021308180A1 (en) * 2020-07-13 2023-03-02 Advansix Resins & Chemicals Llc Branched amino acid surfactants for cleaning products

Also Published As

Publication number Publication date
KR20230051181A (ko) 2023-04-17
JP2023534938A (ja) 2023-08-15
US11857515B2 (en) 2024-01-02
US20220016248A1 (en) 2022-01-20
MX2023000604A (es) 2023-02-13
CA3185041A1 (en) 2022-01-20
ZA202301109B (en) 2024-04-24
AU2021307397A1 (en) 2023-03-02
WO2022015675A1 (en) 2022-01-20
EP4178537A1 (en) 2023-05-17
CN116113398A (zh) 2023-05-12

Similar Documents

Publication Publication Date Title
BR112022012216A2 (pt) Formulação de cuidado de saúde sólida, formulação líquida para cuidado de saúde, e emulsão para cuidados de saúde
BR112022017690A2 (pt) Formulação de cuidado de saúde sólida, formulação líquida para cuidado de saúde, e emulsão para cuidados de saúde
Fox et al. Treatment modalities for acne
Garg et al. Comprehensive review on additives of topical dosage forms for drug delivery
JP2022507451A (ja) 強化された透過性を有するナノエマルジョン組成物
El-Say et al. Diacerein niosomal gel for topical delivery: development, in vitro and in vivo assessment
EP3131531B1 (en) Topical compositions for pain relief, manufacture and use
Miastkowska et al. Nanoemulsion gel formulation optimization for burn wounds: Analysis of rheological and sensory properties
ES2560953T3 (es) Extractos de plantas combinados para usar en el tratamiento de infecciones microbianas
Arsenie et al. Azelaic acid-willow bark extract-panthenol–Loaded lipid nanocarriers improve the hydration effect and antioxidant action of cosmetic formulations
BR112019017018A2 (pt) formulações de canabinoides para o tratamento de dermatite e doenças de pele inflamatórias
Thawabteh et al. Skin pigmentation types, causes and treatment—a review
US20220110860A1 (en) Transdermal formulations
US20210401770A1 (en) Transdermal formulation for the treatment of pain and/or inflammation
KR20220044558A (ko) 칸나비디올을 포함하는 외용 제제, 조성물의 제조 방법 및 이의 용도
Ramanauskienė et al. Assessment of lemon balm (Melissa officinalis L.) hydrogels: quality and bioactivity in skin cells
Vater et al. Lecithin-based nanoemulsions of traditional herbal wound healing agents and their effect on human skin cells
Caliskan et al. Essential oils as skin permeation boosters and their predicted effect mechanisms
Abate et al. Keratinocytes migration promotion, proliferation induction, and free radical injury prevention by 3-hydroxytirosol
BR112023000521A2 (pt) Tensoativos de aminoácidos ramificados para uso em produtos de cuidados com a saúde
US20100261795A1 (en) Antiacneic compositions
JP6240626B2 (ja) 抗アトピー性皮膚炎用組成物
KR102368646B1 (ko) 상온 유화 공정을 이용한 아토피 개선 로션
US8900601B2 (en) Permeable mixtures, methods and compositions for the skin
CN105982886A (zh) 青蒿素衍生物在制备酒渣鼻治疗药物上的应用